Found: 4
Select item for more details and to access through your institution.
The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00457
- By:
- Publication type:
- Article
Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 9, p. 1089, doi. 10.1001/jamaneurol.2020.1118
- By:
- Publication type:
- Article
Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 6, p. 2041, doi. 10.1007/s40120-023-00539-9
- By:
- Publication type:
- Article
Increased IL-2 and Reduced TGF-β Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis.
- Published in:
- Biomedicines, 2020, v. 8, n. 7, p. 226, doi. 10.3390/biomedicines8070226
- By:
- Publication type:
- Article